TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $13.52 -0.63 (-4.45%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$12.91 -0.61 (-4.50%) As of 05:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Stock Price Performance The TransCode Therapeutics (RNAZ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.94%, with a year-to-date return of -85.67%. In the past month, the stock has increased 24.49%, reflecting recent market activity. As of the latest close, TransCode Therapeutics traded at $13.52 with a market cap of $11.22 million and volume of 75,645 shares. Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-8.53%1 Month Performance+24.49%3 Month Performance+48.41%Year-To-Date Performance-85.67%1 Year Performance-99.94% RNAZ Stock Chart for Tuesday, October, 14, 2025 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$14.15$13.52-4.45%$14.32$13.5075,645 shs$11.22 million10/10/2025$14.78$14.15-4.26%$15.94$13.87123,612 shs$11.74 million10/09/2025$14.80$14.78-0.14%$15.50$13.00218,916 shs$12.33 million10/08/2025$11.94$14.80+23.96%$20.99$13.187.49 million shs$12.28 million10/07/2025$11.80$11.94+1.18%$12.22$11.5215,958 shs$9.91 million10/06/2025$10.56$11.80+11.74%$12.31$10.4154,616 shs$9.84 million10/03/2025$10.45$10.56+1.05%$10.74$10.325,587 shs$8.81 million10/02/2025$10.86$10.45-3.78%$11.00$10.5810,110 shs$8.67 million10/01/2025$10.79$10.86+0.65%$11.01$10.616,214 shs$9.01 million09/30/2025$10.63$10.79+1.54%$10.82$10.119,141 shs$9.00 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$10.17$10.63+4.48%$10.70$9.978,360 shs$8.82 million09/26/2025$9.92$10.17+2.52%$10.33$9.8626,708 shs$8.44 million09/25/2025$10.41$9.92-4.72%$10.55$9.8121,163 shs$8.23 million09/24/2025$10.46$10.41-0.47%$10.85$10.007,439 shs$8.68 million09/23/2025$11.18$10.46-6.47%$10.98$10.3617,955 shs$8.68 million09/22/2025$11.69$11.18-4.33%$11.68$11.005,246 shs$9.28 million09/19/2025$11.38$11.69+2.73%$11.88$10.9813,291 shs$9.70 million09/18/2025$11.36$11.38+0.17%$11.80$11.1512,067 shs$9.45 million09/17/2025$11.67$11.36-2.66%$11.76$11.158,091 shs$9.43 million09/16/2025$10.95$11.67+6.58%$11.68$10.9412,437 shs$9.69 million09/15/2025$10.86$10.95+0.83%$11.29$10.878,374 shs$9.09 million Related Companies Klotho Neurosciences Stock Chart ImageneBio Stock Chart Tenax Therapeutics Stock Chart SCYNEXIS Stock Chart AlloVir Stock Chart Iterum Therapeutics Stock Chart PyroGenesis Canada Stock Chart Akari Therapeutics Stock Chart Dare Bioscience Stock Chart Cadrenal Therapeutics Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
